Gathering leading experts from Europe, the program will explore for the first day the intricate links between infection and inflammation, shedding light on how their interplay contributes to disease complications across the lifespan.
The second day will focus on innovations to prevent complications and resistance, culminating in a dedicated session on innovative treatments and vaccines that could transform future therapeutic approaches. Special sessions will also be held during the congress to present the research conducted as part of the CPER “Resist-omics” project.
Scientific pre-program:
Day 1: Complications of inflammatory and infectious diseases
Tuesday, December 8
Registration begins at 09:00, with the first presentation at 09:10; lunch from 12:15 to 13:30; cocktail reception and poster session from 18:15 to 19:30.
Session 1: Infection and inflammation: Partners in crime
Mihai Netea (Radboud university medical center, Nijmegen, The Netherlands)
« Trained immunity: long-term reprogramming of innate immune responses »
Andreas Wack (The Francis Crick Institute, London, UK)
« Long-term impact of acute respiratory infections on lung immunity: The macrophage perspective »
Mariateresa Coppola (Leiden University Medical Center, The Netherlands)
« Parasites Leave Their Mark: Immune Consequences of Exposure »
Session 2: Complications of inflammatory and infectious diseases
Filip Ottosson (Aalborg University, Denmark)
« Inflammation and Beyond: IMIDs and the Cardiovascular System »
Sabrina Marion (CIIL, Institut Pasteur de Lille, France)
« Latent cerebral Toxoplasma gondii infection exacerbates pathophysiological mechanisms of Alzheimer’s disease »
Rebekka Schneider-Kramann (RWTH Aachen University, Germany)
« From inflammatory niches to fibrosis reversal: targeting stromal–immune crosstalk »
Session 3: Infection and inflammation: Age-related risks, complications and prevention strategies
Robbert Van der Most (VaxxCellence, Antwerp, Belgium)
« Infection, vaccination and risk of dementia: a proposed immunological model »
Laurent Martinez (Toulouse University, France)
« Single-cell immunometabolic T cell profiling to predict healthy aging »
Poster sessions
Day 2: Innovations to prevent or combat complications and resistance
Wednesday, December 9
Registration begins at 09:00, and the conference ends at 16:00.
The afternoon session is scheduled to resume at 13:30.
Christina Düsing (University Hospital Düsseldorf, Germany)
« Emerging strategies for deep B cell depletion for the treatment of autoimmune diseases »
Session 1: Prevention of inflammatory diseases
Andrew Cope (King’s College London, UK)
« Rheumatoid arthritis: risk phenotypes and strategies for prevention »
Session 2: Innovative treatments and vaccines
Marien de Jonge (Radboud University Medical Center, Nijmegen, The Netherlands)
« Closing the gap in protection against pneumococcal infection and disease, a combined mucosal and systemic vaccination approach »
Yves Briers (Laboratory of Applied Biotechnology (L.A.B.), Ghent University, Belgium)
« Engineering customized and microbiome-friendly phage-inspired antibiotics »
Alain Baulard (CIIL, Institut Pasteur de Lille, France)
« Alpibectir/Ethionamide (AlpE) – The Long and Winding Road to a New Therapeutic Concept »